ethyl 3-{[2-(morpholin-4-yl)ethyl]amino}propanoate, 95.0%, 2g

1-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 25g

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one, 98%, 5g

5-Pyrimidinecarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-3-fluorophenyl]-3-(4-fluorophenyl)-1,2,3,4-tetrahydro-1-(1-methylethyl)-2,4-dioxo-, 98%, 100mg

(2S)-2-(2,5-Difluorophenyl)-1-[(S)-(1,1-dimethylethyl)sulfinyl]pyrrolidine, 97%, 100mg

Indigo (CI 73000), synth., 50 g, emballage verre

Diethylene Glycol Monododecyl Ether, 98%, 1g

N-METHOXY-N-METHYL-1H-IMIDAZOLE-1-CARBOXAMIDE, 95.0%, 25g

1,1-Dimethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 250mg

Ethyl 1-methyl-1H-indole-6-carboxylate, 97%, 1g

Clothianidin>98.0%(HPLC)1g

1-(4-Amino-phenyl)-1,2,3-triazole, 95.0%, 5g

2-Bromo-3,5-difluorophenol, 98.0%, 100g